| Literature DB >> 29445123 |
Daniel R Richardson1, Ying Huang2, Heather L McGinty3, Patrick Elder2, Joanna Newlin4, Cyndi Kirkendall4, Leslie Andritsos2, Don Benson2, William Blum5, Yvonne Efebera2, Sam Penza2, Craig Hofmeister2, Samantha Jaglowski2, Rebecca Klisovic5, Sumithira Vasu2, Basem William2, Steven Devine2, Ashley E Rosko2.
Abstract
Hematopoietic cell transplantation (HCT) is an intensive treatment resulting in disease control however subsequent psychosocial distress is common. Screening for psychosocial risk factors that contribute to morbidity is underutilized; moreover, the value in screening is uncertain. We performed a retrospective study of 395 HCT patients who were screened for psychosocial risk using the Transplant Evaluation Rating Scale (TERS). Patients were classified by psychosocial risk as no-risk (TERS = 26.5, 52%) vs. at-risk (TERS > 26.5, 48%), with at-risk patients stratified by cumulative deficits into mild risk (TERS = 27-35.5, 39%) and moderate risk (TERS > 35.5, 9%). At-risk patients were more likely to be readmitted within 90 days (mild risk HR = 1.62, p = 0.02; moderate risk HR = 2.50, p = 0.002). Prior psychiatric history (HR = 1.81, p = 0.002) and poor coping skills (HR = 1.64, p = 0.04) also influenced readmission. At-risk patients were more likely to be readmitted for infection (no-risk = 12% vs. at-risk = 25%, p = 0.002). Pre-HCT screening with the TERS did not predict survival or length of stay although at-risk patients are at a heighted risk of readmission. Implementing strategies to reduce readmission in higher risk patients is warranted.Entities:
Mesh:
Year: 2018 PMID: 29445123 PMCID: PMC6092254 DOI: 10.1038/s41409-018-0118-4
Source DB: PubMed Journal: Bone Marrow Transplant ISSN: 0268-3369 Impact factor: 5.483